Hypera SA is a leading pharmaceutical company in Brazil, specializing in both specialty and generic drugs. With a strong focus on the Brazilian market, Hypera SA also offers nonprescription drugs and branded generics. The company boasts a diverse portfolio of products in Consumer Health, Branded Prescription, Similars e Generics, Skincare, and Non-Retail Market segments. Despite its high ESG risk rating score of 33.7, Hypera SA has a wide sales and distribution network, making it a key player in the pharmaceutical industry.